Statement of the American Society for Clinical Pharmacology and Therapeutics on the Drug Regulation Reform Act of 1978 (H.R. 11611).
出版信息
Clin Pharmacol Ther. 1978 Sep;24(3):374-81. doi: 10.1002/cpt1978243374.
PMID:357070
Abstract
摘要
相似文献
1
Statement of the American Society for Clinical Pharmacology and Therapeutics on the Drug Regulation Reform Act of 1978 (H.R. 11611).美国临床药理学与治疗学学会关于1978年药品监管改革法案（众议院第11611号法案）的声明。
Clin Pharmacol Ther. 1978 Sep;24(3):374-81. doi: 10.1002/cpt1978243374.
2
The effect of the Drug Regulation Reform Act of 1978 on clinical research, drug availability, and the public health.1978年《药品监管改革法案》对临床研究、药品可及性及公众健康的影响。
Ann N Y Acad Sci. 1981;368:175-85. doi: 10.1111/j.1749-6632.1981.tb15447.x.
3
Statement of the American College of Clinical Pharmacology on Drug Regulation Reform Act.
J Clin Pharmacol. 1979 Feb-Mar;19(2-3):165-6. doi: 10.1002/j.1552-4604.1979.tb02475.x.
4
The DESI hit list: the story and reflections.DESI打击名单：故事与反思。
J Am Acad Dermatol. 1981 Sep;5(3):363-6. doi: 10.1016/s0190-9622(81)80165-x.
5
The relationships of the American Society for Clinical Pharmacology and Therapeutics to government.美国临床药理学与治疗学协会与政府的关系。
Clin Pharmacol Ther. 1990 Feb;47(2):287-90.
6
Medicines, governments and doctors.药品、政府和医生。
Drugs. 1972;3(5):305-13. doi: 10.2165/00003495-197203050-00001.
7
Clinical trials and the drug review process.临床试验与药物审评过程。
Chest. 1978 Jun;73(6 Suppl):967-71. doi: 10.1378/chest.73.6_supplement.967.
8
Patients' needs in drug development and regulation.患者在药物研发与监管方面的需求。
Ann N Y Acad Sci. 1981;368:187-202. doi: 10.1111/j.1749-6632.1981.tb15448.x.
9
Dying to live.向死而生。
Nat Med. 2006 Jun;12(6):593. doi: 10.1038/nm0606-593.
10
Pharmaceutical regulations in the 1980s--predictions.20世纪80年代的药品法规——预测
Drug Intell Clin Pharm. 1982 Apr;16(4):320-4. doi: 10.1177/106002808201600408.
Zotero 插件